1. Home
  2. GAUZ vs IMUX Comparison

GAUZ vs IMUX Comparison

Compare GAUZ & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • IMUX
  • Stock Information
  • Founded
  • GAUZ 2009
  • IMUX 2016
  • Country
  • GAUZ Israel
  • IMUX United States
  • Employees
  • GAUZ N/A
  • IMUX N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAUZ Miscellaneous
  • IMUX Health Care
  • Exchange
  • GAUZ Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • GAUZ 109.1M
  • IMUX 90.4M
  • IPO Year
  • GAUZ 2024
  • IMUX N/A
  • Fundamental
  • Price
  • GAUZ $5.70
  • IMUX $0.95
  • Analyst Decision
  • GAUZ Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • GAUZ 3
  • IMUX 5
  • Target Price
  • GAUZ $13.67
  • IMUX $7.50
  • AVG Volume (30 Days)
  • GAUZ 60.7K
  • IMUX 1.1M
  • Earning Date
  • GAUZ 08-13-2025
  • IMUX 08-07-2025
  • Dividend Yield
  • GAUZ N/A
  • IMUX N/A
  • EPS Growth
  • GAUZ N/A
  • IMUX N/A
  • EPS
  • GAUZ N/A
  • IMUX N/A
  • Revenue
  • GAUZ $96,810,000.00
  • IMUX N/A
  • Revenue This Year
  • GAUZ $28.49
  • IMUX N/A
  • Revenue Next Year
  • GAUZ $47.77
  • IMUX N/A
  • P/E Ratio
  • GAUZ N/A
  • IMUX N/A
  • Revenue Growth
  • GAUZ 7.87
  • IMUX N/A
  • 52 Week Low
  • GAUZ $5.15
  • IMUX $0.56
  • 52 Week High
  • GAUZ $13.00
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ 36.11
  • IMUX 53.93
  • Support Level
  • GAUZ $5.15
  • IMUX $0.89
  • Resistance Level
  • GAUZ $6.00
  • IMUX $1.00
  • Average True Range (ATR)
  • GAUZ 0.36
  • IMUX 0.08
  • MACD
  • GAUZ -0.02
  • IMUX -0.00
  • Stochastic Oscillator
  • GAUZ 36.88
  • IMUX 71.43

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: